Skip to content

Effectiveness of Kegel Exercise Device in Strengthening Pelvic Floor and Treating Urinary Incontinence (UI)

Assessment of the Effectiveness of a Pelvic Exercise Device in Strengthening Pelvic Floor Muscles and Treating Urinary Incontinence

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02617472
Enrollment
93
Registered
2015-12-01
Start date
2015-11-30
Completion date
2017-08-31
Last updated
2017-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sexual Dysfunction, Stress Urinary Incontinence

Brief summary

This study will assess the effectiveness of a new pelvic floor exercise device in strengthening pelvic floor muscles and treating urinary incontinence among women who are experiencing symptoms of pelvic floor weakness. The study will be conducted over 12 weeks and results will be collected through self-assessment questionnaires and clinical pelvic examination. Effectiveness outcomes will be tracked over the duration of the trial and measured against historical symptoms.

Detailed description

The objective of the study is to test the device with women who are experiencing symptoms of pelvic floor weakness, namely urinary incontinence, vaginal laxity and sexual sensation problems, to assess the changes in pelvic floor muscle strength, before and after the intervention. The study device is a pelvic floor exercise device that provides biofeedback and exercise guidance. Women who meet the inclusion criteria will be recruited from the regular patients at the investigation site and given the device to use at home daily for 12 weeks. Subjects will submit information regarding their experience with the device and self-assessed improvements in their symptoms. A pelvic examination will be conducted at the start and conclusion of the study to measure a pelvic floor muscle strength reading. The research hypothesis is that strength level, subjective assessment of vaginal tightness and sexual sensations will be greater at the end of the study than at the baseline and the mean value of frequency and volume of bladder leaks will be less than at the baseline.

Interventions

DEVICEPelvic floor exerciser

Daily exercise using the study device

Sponsors

Banner Health
CollaboratorOTHER
Lelo Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 69 Years
Healthy volunteers
No

Inclusion criteria

1. Subject provides written informed consent and HIPAA authorization before any study procedures are conducted; 2. Experience urinary incontinence and/or vaginal laxity and/or decreased sexual sensation for a period of 6 weeks or more.

Exclusion criteria

1. Subject has any condition or exhibits behavior that indicates to the Principal Investigator that the Subject is unlikely to be compliant with study procedures and visits 2. Has had prior surgery for incontinence, prolapse or vaginal tightening 3. Has been diagnosed with pelvic organ prolapse more severe than grade 2 4. Suffers from vaginal penetration difficulties 5. Has had more than 3 urinary tract infections in the past 12 months 6. Has any conditions of the bladder that effect continence 7. Suffer from vaginal/vulvar/pelvic pain 8. Is currently taking any medication for incontinence 9. Is pregnant or trying to become pregnant 10. Has given birth less than 6 weeks prior to enrollment 11. Has been diagnosed obese - BMI \> 30 12. Is a heavy smoker - \> 20 cigarettes per day 13. Has a history of neurological conditions - Parkinson's, multiple sclerosis and other 14. Suffers from chronic constipation

Design outcomes

Primary

MeasureTime frameDescription
Change in pelvic floor strength12 weeksPelvic floor strength measured by a clinical perineometer in cm H2O. A baseline measurement of resting and peak muscle contraction values will be recorded at the start before the intervention and after the 12 weeks of treatment.

Secondary

MeasureTime frameDescription
Frequency of bladder leaks.12 weeksReporting of weekly incidence of bladder leaks.
Volume of bladder leaks12 weeksReporting of weekly average volume of bladder leaks.A subject assessment with very distinct category gradations.

Other

MeasureTime frameDescription
Subjective assessment of vaginal tightness12 weeksSubjective assessment of increased vaginal tone.
Subjective assessment of sexual sensations12 weeksSubjective assessment based on questions that rate this quality of life parameter.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026